Remove Marketing Remove Pricing Remove Product Remove Thousand Oaks
article thumbnail

Ceres Prices IPO

socalTECH

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150
article thumbnail

Xirrus Aims At Disaster Teams, Event Organizers

socalTECH

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking equipment, announced Monday that it has put together a portable, pre-packaged kit which is designed for deploying Wi-Fi into disaster response and temporary events. The firm said it would offer the new product online, priced starting at $3,999.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interview with Brett Crosby and Brew Johnson, PeerStreet

socalTECH

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Those loans are very mis-priced, in our opinion. I worked on several products, and launched many things. There's a massive market, and there is no end to the opportunities here to create efficiency and transform things for the better.

article thumbnail

Makers Making The Sci-Fi Tricorder A Reality With VOXearch

socalTECH

Unfortunately, those providers decided the gold leads were expensive, and decided to use a Chinese vendor which would provide them at half price. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.

Startup 262
article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

Just as many M&A rumors flame out as lead to deals, of course, but the news was enough to give Biogen’s stock price a big bump, and ignite chatter about what a sale of one of biotech’s heavyweights would mean, particularly for the Boston area. The rumors boosted Biogen’s sinking stock price nearly 10 percent.

News 40